Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome
Status:
Completed
Trial end date:
2016-11-11
Target enrollment:
Participant gender:
Summary
This randomized pilot clinical trial studies whether auranofin will relieve pain following
paclitaxel in patients who have previously experienced paclitaxel-induced pain. Auranofin is
a drug given by mouth to treat other diseases such as rheumatoid arthritis, and is being
studied to see if it will decrease pain following paclitaxel.